MSCI (NYSE:MSCI) Stock, Quote.Headers.trade-ideas

MSCI

MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1.4 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In private assets, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.

nasdaq shutter

News

Price Target

Reiteration

Analyst Ratings

Movers

Tech

Trading Ideas

JKHY

MLNK

NCNO

NDAQ

SPGI

BofA Securities double-upgraded Nasdaq stock (NDAQ) and raised its price target to $90 due to strong financials and potential for growth in IPOs.

IPO Rebound And FinTech Growth Potential Is Helping Nasdaq: Analyst Double Upgrades Stock

jim cramer chart shutter

Long Ideas

Markets

Media

PANW

Jim Cramer likes MSCI, RPM, and DuPont. He recommends buying Palo Alto. New Fortress Energy is facing issues and Barclays lowered their target.

Jim Cramer Calls This Tech Stock &#39;Terrific&#39; And Says &#39;I Heavily Suggest That You Buy Much More&#39; Of DuPont

Wall-Street-ai5

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Large Cap

Broad U.S. Equity ETFs

Commodities

Small Cap

Econ #s

ETFs

AGYS

CMCSA

SPDR Dow Jones Industrial Average ETF Trust

GOOG

GOOGL

MEDP

NXPI

SPOT

TSLA

Tuesday&#39;s Wall Street session was mixed, with small-caps outperforming large-caps as investors awaited earnings from Alphabet Inc. and Tesla Inc.

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What&#39;s Driving Markets Tuesday?

MSCI Inc

MSCI ACWI UCITS ETF

MSCI ALL CHINA HLTH CARE UCITS ETF USD

MSCI CHI ESG LDRS UCITS ETF

MSCI KOREA INDEX UCITS (DR) 1C ETF

MSCI ORD

MSCI SDG 11 ETF

MSCI SDG 12 ETF

MSCI USA SC ESG ETF

MSCI USA TRN INDEX SF A USD ETF

MSCI WS CAP ETF

Barclays analyst Manav Patnaik maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $650 to $700.

Barclays Maintains Overweight on MSCI, Raises Price Target to $700

Nasdaq Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) stock gained after B of A Securities analyst Craig Siegenthaler <a target="_blank" href="https://www.benzinga.com/quote/NDAQ/analyst-ratings" rel="noreferrer noopener">double-upgraded the stock</a> from Underperform to Buy and raised its price target from $53 to $90.
Siegenthaler applied a 25x multiple on his 2026 EPS to derive the price target. The multiple implies a slight discount to Nasdaq&#8217;s aspirational software and information services peer group but is a premium to its current valuation.
The analyst highlighted that the solutions segment now comprises 78% of revenue. Information services peers like S&amp;P Global Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>), Moody&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>), and MSCI Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) trade at 30x 2026E earnings and have a fair amount of overlap with Nasdaq&#8217;s Capital Access Platforms segment, the analyst said.
Similarly, its FinTech segment comprises 36% of group revenue, with management guiding toward 10%-14% growth over the medium term. Other financial vertical software companies MeridianLink, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>), nCino, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>), and Jack Henry &amp; Associates, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) with comparable growth profiles are trading around 30x-40x EPS, the analyst noted. Nasdaq, however, trades at just 21x consensus 2026 EPS, he added.
The analyst noted an upward rerating would stem from a pause in dealmaking, accelerated deleveraging, business streamlining, and an acceleration in revenue growth.
As per Siegenthaler, improving macroeconomic conditions in conjunction with long backlogs should make for an IPO rebound in 2025.
Specifically, equity market valuations have recovered to 2021 levels while volatility should normalize lower after the U.S. presidential election and Fed rate cuts, the analyst said.
At the same time, he added that private equity sponsors have a long pipeline of aging portfolio companies, and limited partners are demanding liquidity.
He said that a comeback in IPOs would directly benefit Nasdaq&#8217;s listings segment and have positive second-derivative impacts on its trading, corporate services, and financial data businesses.
Price Action: NDAQ stock traded higher by 2.22% at $72.97 at the last check on Wednesday.
Photo via Shutterstock

AAPL

ASML

Third Point LLC Q2 2024 13F Shows New Positions Include 1.95M Apple Shares, 2.8M Amphenol Shares, 2.1M KB Home Shares, 1.37M Live Nation Shares, 275K Micron Shares, 240K Roper Technologies Shares, 150K MSCI Shares, 150K Dynatrace Shares, 80K ASML Shares, 650K CRH Shares, And 625K Hess Shares

Wells Fargo analyst Jason Haas initiates coverage on MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Equal-Weight rating and announces Price Target of $570.

Initiation

Wells Fargo Initiates Coverage On MSCI with Equal-Weight Rating, Announces Price Target of $570

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said he wants to own the stock of MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>).
On July 23, MSCI posted better-than-expected second-quarter financial results. MSCI reported fiscal 2024 second-quarter revenue growth of 14.0% year-on-year to $707.95 million, beating the analyst consensus e<a href="https://www.benzinga.com/news/earnings/24/07/39912184/msci-q2-earnings-impress-investors-ceo-emphasizes-on-robust-client-base-and-execution">stimate of $696.37 million</a>.
Cramer said he likes the business of New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>), but something's going wrong there. &#8220;I can't figure out how to turn the stock around,&#8221; he added.
On Aug. 5, Barclays analyst Theresa Chen maintained New Fortress Energy with an Equal-Weight and lowered the price target from $27 to $19.
The Mad Money host recommended holding on to RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>). &#8220;That is one great company, it's an under the radar one, and I want you to own it,&#8221; he added.
On July 25, RPM International reported better-than-expected fourth-quarter earnings.
&#8220;I heavily suggest that you buy much more DuPont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>),&#8221; Cramer said.
On July 31, DuPont De Nemours reported better-than-expected second-quarter adjusted EPS and sales. Sales rose 2% Y/Y to $3.171 billion, beating the consensus of $3.049 billion. Organic sales remained flat Y/Y, with a 2% increase in volume offset by a 2% decrease in price.
Cramer recommended buying Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) and added that it is &#8220;terrific.&#8221;
Palo Alto will release the financial results for its fiscal fourth quarter and fiscal year 2024, after the closing bell on Monday, Aug. 19.
Price Action:
<ul>
<li>MSCI shares gained 1.7% to settle at $526.11 on Tuesday.</li>
<li>New Fortress Energy shares rose 1.6% to close at $16.40.</li>
<li>RPM shares gained 0.3% to close at $115.01.</li>
<li>DuPont shares gained 0.3% to settle at 78.05 on Tuesday.</li>
<li>Palo Alto shares rose 2.6% to close at $301.93 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40194186/top-4-materials-stocks-which-could-rescue-your-portfolio-this-month">Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month</a></li>
</ul>
Photo: Shutterstock

Jim Cramer Calls This Tech Stock 'Terrific' And Says 'I Heavily Suggest That You Buy Much More' Of DuPont

NFLX

NVDA

Morgan Stanley Wealth Management Increases Portfolio Weights In Eli Lilly, Northrop Grumman Corp, Nvidia, MSCI; Decreases Portfolio Weights In JP Morgan Chase & Co, Palo Alto Networks, Netflix, NextEra Energy

Argus Research analyst John Eade maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Buy and raises the price target from $520 to $600.

Argus Research Maintains Buy on MSCI, Raises Price Target to $600

Barclays analyst Manav Patnaik maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $600 to $650.

Barclays Maintains Overweight on MSCI, Raises Price Target to $650

RBC Capital analyst Ashish Sabadra reiterates MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Outperform and maintains $638 price target.

RBC Capital Reiterates Outperform on MSCI, Maintains $638 Price Target

Goldman Sachs analyst George Tong maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Neutral and raises the price target from $526 to $590.

Goldman Sachs Maintains Neutral on MSCI, Raises Price Target to $590

Morgan Stanley analyst Toni Kaplan maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Overweight and raises the price target from $615 to $640.

Morgan Stanley Maintains Overweight on MSCI, Raises Price Target to $640

On Tuesday, Wall Street saw a mixed session, with small-cap stocks outperforming large caps as investors anticipated key earnings reports from Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), set to be <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39910693/tesla-analyst-asks-do-earnings-matter-ahead-of-q2-report-robotaxis-china-ev-guidanc">released after the close.</a>
The Russell 2000 index, as replicated by the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), climbed 0.8%, while the tech-heavy Nasdaq 100 dipped 0.2%. This marked the ninth time in the last 10 sessions that small caps have outperformed tech stocks. The S&amp;P 500 and the Dow Jones showed little movement.
United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) stood out among the mega-cap stocks, plunging 14% after missing earnings and revenue estimates for the previous quarter. This decline is poised to be the worst one-day drop for the shipping company since it went public in 1999.
Both Treasury yields and the U.S. dollar remained stable ahead of a data-heavy week, featuring the Q2 GDP report on Thursday and the Fed&#8217;s favored inflation report on Friday.
Gold inched up 0.3%, reaching $2,400 per ounce, while Bitcoin dropped over 2% to $65,800, marking its second straight session of losses.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,243.00</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,568.86</td>
<td>0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,386.54</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,778.53</td>
<td>-0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:48 p.m. ET</figcaption></figure>
According to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent071924&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was flat at $554.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;edged down 0.1% to $403.80.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(ARCA:&nbsp;<a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a><a href="https://www.benzinga.com/quote/qqq" target="_blank" rel="noreferrer noopener"></a>QQQ) fell 0.2% to $481.52.</li>
<li>Sector-wise, the Financials Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)&nbsp;outperformed, up by 0.4%, while the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.4%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
Stocks reacting to company earnings were: 
<ul>
<li>Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>), down over 5%</li>
<li>NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) down over 9%</li>
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) down over 17%</li>
<li>Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), up 0.6%</li>
<li>Freeport-McMoRan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), down 2%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), up over 7%</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), down over 6%</li>
<li>Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down over 4%</li>
<li>Comcast Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>), down over 2%</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>), up over 7%</li>
<li>Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), up over 4%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 2%</li>
<li>PulteGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 0.5%</li>
<li>Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>), down over 4%</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>), up over 10%</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>), down over 2%.</li>
</ul>
Those reporting after the close include:
<ul>
<li>Alphabet, Capital One Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>)</li>
<li>Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>)</li>
<li> Mattel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>)</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>)</li>
<li>Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>)</li>
<li>Tesla</li>
<li>Texas Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</li>
<li>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>).</li>
</ul>
Read Next:
<ul>
<li><a href="https://bzresearch.myclickfunnels.com/latest-research-webinar-redirect-evergreen?utm_source=website-content" target="_blank" rel="noreferrer noopener">Turn Trading Into The Ultimate Side Hustle Using Benzinga Tools In A Free Webinar</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?

Shares of Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) fell sharply during Tuesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39908857/comcasts-q2-earnings-studios-and-theme-parks-pull-revenue-lower-broadband-and-video-subs-fall">second-quarter sales results</a>.
Comcast reported second-quarter revenue decline of 2.7% year-over-year to $29.69 billion, missing the analyst consensus estimate of $30.02 billion.The company reported adjusted EPS of $1.21, beating analyst consensus estimates of $1.12, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Comcast shares declined 6.1% to $37.12 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares jumped 529% to $10.19 after the company announced that the U.S. Patent and Trademark Office granted it U.S. Patent No. 12,036,248 for the treatment of atopic dermatitis.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) jumped 148% to $2.6299 after the company announced it advanced into the second cohort and commenced dosing for the Pharmacokinetics Study of AD04 for alcohol use disorder.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) gained 111% to $3.2540.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares climbed 67% to $0.2390.</li>
<li>Smart for Life, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMFL#NASDAQ">SMFL</a>) rose 45% to $2.7950.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) gained 43% to $2.41.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 36.5% to $4.60.</li>
<li>Volato Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#NYSE">SOAR</a>) gained 33.5% to $0.6385 after jumping around 20% on Monday.</li>
<li>Frequency Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) shares climbed 30% to $13.11 following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.</li>
<li>Mammoth Energy Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TUSK#NASDAQ">TUSK</a>) gained 26% to $4.42 after the company announced its subsidiary, Cobra Acquisitions, entered into a release and settlement agreement with the Puerto Rico Electric Power Authority.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) rose 23.5% to $2.05.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) jumped 19.3% to $2.90.</li>
<li>Milestone Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#NYSE">MLSS</a>) gained 17.5% to $1.02 after the company announced the Medicare price assignment for its CompuFlo Epidural System.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) gained 16% to $2.1493.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) rose 16% to $24.81 after the company reported better-than-expected second-quarter sales results and raised its FY24 net product revenue guidance.</li>
<li>Aeva Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) gained 15.1% to $3.6713.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) jumped 12.7% to $333.02 following second-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) gained 11.8% to $12.34.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) rose 11.8% to $6.90.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) gained 11.1% to $561.96 following better-than-expected second-quarter financial results.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) rose 8.5% to $84.04 after the company reported better-than-expected second-quarter earnings and raised its FY24 EPS guidance above estimates.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) gained 8% to $96.75 following better-than-expected quarterly earnings.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) gained 8% to $16.51 as the company released preliminary second quarter 2024 financial results and signed a definitive agreement to acquire Rotech Healthcare for $1.36 billion in cash.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares surged 8% to $8.15. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) climbed 7.7% to $86.19 after the company reported better-than-expected second quarter financial results and revised its FY24 adjusted EPS guidance above estimates.</li>
<li>Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) gained 7.4% to $269.35 after the company reported better-than-expected second quarter earnings.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) gained 6.4% to $173.21 after the company reported better-than-expected second quarter adjusted EPS and raised its FY24 outlook.</li>
<li>SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) rose 6% to $0.2390 after the company reported second-quarter financial results.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) gained 5.4% to $52.12 after posting better-than-expected quarterly results on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Jaguar Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares dipped 65% to $1.50 after the company announced its phase 3 OnTarget trial results for Crofelemer did not meet its primary endpoint.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) dipped 62.2% to $0.2999 after the company announced a proposed public offering.</li>
<li>Fly-E Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) tumbled 59.2% to $2.60.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares dipped 50.3% to $2.4636. MIRA Pharmaceuticals shares jumped 627% on Monday after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares fell 38.3% to $3.1851 after surging 228% on Monday.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) dipped 32.4% to $0.0250.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) fell 32.2% to $1.83.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) fell 31.1% to $0.3440.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) dipped 26.2% to $2.23. The company announced results from its CLOVER WaM pivotal study evaluating iopofosine I 131.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) fell 23% to $0.77.</li>
<li>Castellum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>) fell 20% to $0.1594. Castellum recently announced a new strategic alliance with Krilla Kaleiwahea.</li>
<li>Netcapital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) fell 17.3% to $0.0926 after gaining around 8% on Monday.</li>
<li>Medpace Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) shares declined 16.6% to $364.00 after the company reported mixed second-quarter financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) dipped 15.2% to $16.48.</li>
<li>United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) fell 13.2% to $126.04 after the company reported worse-than-expected quarterly financial results.</li>
<li>Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares fell 10% to $0.4479 after gaining over 55% on Monday.</li>
<li>NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) shares fell 9.5% to $256.55 following mixed second-quarter earnings.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) dipped 9.2% to $23.28.</li>
<li>PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) fell 8.4% to $99.92 after the company reported worse-than-expected second-quarter financial results.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) declined 8.4% to $81.30. The company reported second-quarter financial results.</li>
<li>WEBTOON Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBTN#NASDAQ">WBTN</a>) dipped 7.7% to $22.00.</li>
<li>Polaris Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PII#NYSE">PII</a>) declined 7.2% to $76.23 after the company reported worse-than-expected second-quarter financial results and cut its guidance.</li>
<li>Archrock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) shares declined 6.9% to $21.76. Archrock commenced public offering of 11 million shares of its common stock and announced plans to acquire Total Operations and Production Services for $983 million in cash and stock.</li>
<li>General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) fell 6.1% to $46.52 after the company reported second-quarter financial results. Also, the company announced that it delayed its 2024 Buick EV and pushed its EV pickup plant opening to 2026.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907957/microsoft-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday">Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Intraday Update

ADIL

AEVA

AROC

ATPC

AZTR

CGBS

CLRB

CMAX

DRMA

EFSH

FEIM

FLYE

FTEL

ICLK

JAGX

KNSA

MESO

MIRA

MLSS

MMYT

NCPL

NUKK

PCAR

PSIG

RNAZ

SLNA

SLRX

SMFL

SOAR

STAF

TUSK

WBTN

XCUR

ZION

Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

MSCI Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) reported fiscal 2024 second-quarter revenue growth of 14.0% year-on-year to $707.95 million, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39901915/msci-reports-financial-results-for-second-quarter-and-six-months-2024" rel="noreferrer noopener">analyst consensus estimate of $696.37 million</a>.&nbsp;
The adjusted EPS of $3.64 beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $3.55</a>. The stock price gained after the results.
The total&nbsp;run-rate at&nbsp;June 30, 2024, rose 14.6%&nbsp;Y/Y&nbsp;to $2.81 billion.&nbsp;The organic&nbsp;recurring subscription run rate growth was 8.6%. The retention rate was 94.8% compared to 95.5% last year.
The investment research firm&#8217;s index operating revenues rose 9.6% year over year to $397.2 million, aided by higher recurring subscription revenues and asset-based fees.
Analytics operating revenues increased 10.8%&nbsp;Y/Y&nbsp;to $166.0 million, driven by higher recurring subscription revenues from Equity and Multi-Asset Class Analytics products.
ESG and Climate operating revenues grew 12.1%&nbsp;year over year&nbsp;to $79.9 million, driven by solid growth in&nbsp;Ratings, Screening, and Climate products.
All&nbsp;Other&nbsp;–&nbsp;Private Assets&nbsp;operating revenues improved 72.0% Y/Y to $64.9 million.
Margin: The operating margin declined from 55.7% to 54.0%. The adjusted EBITDA margin was stable at 60.7%.
MSCI generated $321.9 million in free cash flow and held $451.4 million in cash and equivalents&nbsp;as of June 30, 2024.
Dividend: The board declared a dividend per share of $1.60 for the third quarter.
&#8220;MSCI&#8217;s second quarter results demonstrate the strength of our all-weather franchise, our blue-chip client base, our wide range of solutions, and our relentless focus on execution,&#8221; said Henry A. Fernandez, Chairman and CEO of MSCI.
FY24 Outlook: MSCI&nbsp;expects operating expense of $1.305 billion &#8211; $1.345 billion (<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38383493/whats-going-on-with-msci-stock-on-monday" rel="noreferrer noopener">prior $1.30 billion&nbsp;– $1.34&nbsp;billion</a>), reiterated capex of $95 million&nbsp;– $105&nbsp;million, and free cash flow of $1.225 billion&nbsp;– $1.285&nbsp;billion.
The&nbsp;fiscal revenue and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">adjusted EPS consensus</a> are $2.83 billion and $14.70.
Price Action:&nbsp;MSCI shares traded higher by 7.46% at $543.77 at the last check on Tuesday.

Earnings

Guidance

MSCI Q2 Earnings Impress Investors, CEO Emphasizes On Robust Client Base and Execution

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Tuesday.
Shares of Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39907956/life-science-giant-danahers-q2-earnings-beat-estimates-on-sustained-positive-momentum-in-bioprocess">second quarter earnings</a>.
Danaher's second quarter sales decreased 3% year-over-year to $5.743 billion, beating the consensus of $5.59 billion. Danaher reported second-quarter adjusted EPS of $1.72, beating the consensus of $1.57, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Danaher shares gained 7.4% to $269.35 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) shares jumped 16% to $24.81 after the company reported better-than-expected second-quarter sales results and raised its FY24 net product revenue guidance.</li>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) gained 12.7% to $333.02 following second-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) surged 11.8% to $12.34.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) gained 11.8% to $6.90.</li>
<li>KKR Real Estate Finance Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KREF#NYSE">KREF</a>) surged 11.2% to $11.22 following second-quarter results.</li>
<li>MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) shares jumped 11.1% to $561.96 following better-than-expected second-quarter financial results.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) gained 10.3% to $66.27.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) gained 9% to $29.48. HC Wainwright &amp; Co. analyst Patrick Trucchio initiated coverage on Beam Therapeutics with a Buy rating and announced a price target of $80.</li>
<li>Iridium Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>) rose 8.5% to $28.11 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 8.5% to $84.04 after the company reported better-than-expected second-quarter earnings and raised its FY24 EPS guidance above estimates.</li>
<li>MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) climbed 8% to $96.75 following better-than-expected quarterly earnings.</li>
<li>Inter Parfums, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) gained 8% to $137.34 after the company reported better-than-expected expected sales.</li>
<li>Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) rose 8% to $16.51 as the company released preliminary second quarter 2024 financial results and signed a definitive agreement to acquire Rotech Healthcare for $1.36 billion in cash.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares gained 8% to $8.15. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) gained 7.7% to $86.19 after the company reported better-than-expected second quarter financial results and revised its FY24 adjusted EPS guidance above estimates.</li>
<li>Park National Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRK#NYSE">PRK</a>) gained 7.4% to $182.78 following upbeat quarterly earnings.</li>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) gained 7.1% to $3.46.</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) shares surged 6.4% to $173.21 after the company reported better-than-expected second quarter adjusted EPS and raised its FY24 outlook.</li>
<li>SAP SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) gained 6% to $0.2390 after the company reported second-quarter financial results.</li>
<li>Hims &amp; Hers Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NASDAQ">HIMS</a>) gained 5.6% to $21.51.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) surged 5.5% to $178.95.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) rose 5.4% to $52.12 after posting better-than-expected quarterly results on Monday.</li>
<li>Brown &amp; Brown, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) gained 5.2% to $97.99 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39907046/best-buy-kroger-and-2-other-stocks-insiders-are-selling">Best Buy, Kroger And 2 Other Stocks Insiders Are Selling</a></li>
</ul>

BEAM

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IPAR

IRDM

KREF

Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

WIIM

MSCI shares are trading higher following better-than-expected Q2 financial results.

Full-Year 2024&nbsp;Guidance
MSCI&#39;s&nbsp;guidance&nbsp;for the year ending December 31, 2024 (&quot;Full-Year 2024&quot;) is based on assumptions about a number of factors, in particular related to macroeconomic factors and the capital markets. These assumptions are subject to uncertainty, and actual results for the year could differ materially from our current&nbsp;guidance, including as a result of the uncertainties, risks and assumptions discussed in the &quot;Risk Factors&quot; and &quot;Management&#39;s Discussion and Analysis of Financial Condition and Results of Operations&quot; sections of our Annual Report on Form 10-K, as updated in quarterly reports on Form 10-Q and current reports on Form 8-K filed or furnished with the SEC. See &quot;Forward-Looking Statements&quot; below.
<table cellspacing="0">
<tbody>
<tr>
<td colspan="1" rowspan="1">
Guidance&nbsp;Item
</td>
<td colspan="1" rowspan="1">
Current&nbsp;Guidance&nbsp;for Full-Year 2024
</td>
<td colspan="1" rowspan="1">
Prior&nbsp;Guidance&nbsp;for Full-Year 2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Operating Expense
</td>
<td colspan="1" rowspan="1">
$1,305&nbsp;to&nbsp;$1,345&nbsp;million
</td>
<td colspan="1" rowspan="1">
$1,300&nbsp;to&nbsp;$1,340&nbsp;million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted EBITDA
Expense
</td>
<td colspan="1" rowspan="1">
$1,130&nbsp;to&nbsp;$1,160&nbsp;million
</td>
<td colspan="1" rowspan="1">
$1,130&nbsp;to&nbsp;$1,160&nbsp;million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Interest Expense
(including amortization
of financing fees)(1)
</td>
<td colspan="1" rowspan="1">
$185&nbsp;to&nbsp;$189 million
</td>
<td colspan="1" rowspan="1">
$185&nbsp;to&nbsp;$189 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Depreciation &amp;
Amortization Expense
</td>
<td colspan="1" rowspan="1">
$175&nbsp;to&nbsp;$185 million
</td>
<td colspan="1" rowspan="1">
$170&nbsp;to&nbsp;$180 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Effective Tax Rate
</td>
<td colspan="1" rowspan="1">
18%&nbsp;to&nbsp;21%
</td>
<td colspan="1" rowspan="1">
18%&nbsp;to&nbsp;21%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capital Expenditures
</td>
<td colspan="1" rowspan="1">
$95&nbsp;to&nbsp;$105 million
</td>
<td colspan="1" rowspan="1">
$95&nbsp;to&nbsp;$105 million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Net Cash Provided by Operating Activities
</td>
<td colspan="1" rowspan="1">
$1,330&nbsp;to&nbsp;$1,380&nbsp;million
</td>
<td colspan="1" rowspan="1">
$1,330&nbsp;to&nbsp;$1,380&nbsp;million
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Free Cash Flow
</td>
<td colspan="1" rowspan="1">
$1,225&nbsp;to&nbsp;$1,285&nbsp;million
</td>
<td colspan="1" rowspan="1">
$1,225&nbsp;to&nbsp;$1,285&nbsp;million
</td>
</tr>
</tbody>
</table>

MSCI Reiterated FY24 Capex of $95M-$105M, Free Cash Flow of $1.225B-$1,285B

Earnings Beats

MSCI Q2 2024 Adj EPS $3.64 Beats $3.55 Estimate, Sales $707.949M Beat $696.369M Estimate

UBS analyst Alex Kramm maintains MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Buy and raises the price target from $575 to $585.

UBS Maintains Buy on MSCI, Raises Price Target to $585

Moody&#39;s Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mco#NYSE">MCO</a>) and MSCI Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msci#NYSE">MSCI</a>) have entered into an agreement to establish a strategic partnership to capitalize on each other&#39;s strengths to enhance transparency in environmental, social, and governance (ESG) and sustainability in markets and make better decisions. The financial terms of the deal remain confidential. 
Moody&#39;s will utilize MSCI&#39;s sustainability data and models, which are widely used by the world&#39;s major asset managers and asset owners. The agreement includes MSCI&#39;s industry-leading ESG ratings and content, which assesses a company&#39;s management of financially significant ESG risks and opportunities.&nbsp; 
Through access to MSCI data, Moody&#39;s plans to migrate its existing ESG data and scores to offer MSCI&#39;s sustainability content through a wide array of solutions serving its customers in the banking, insurance and corporate sectors. 
MSCI will gain accessibility to Moody&#39;s Orbis database, the world&#39;s prominent source of firmographic information with data on more than 500 million entities, to expand its private company ESG coverage. Additionally, both companies will evaluate solutions that utilize Moody&#39;s private company data and credit scoring models to offer deeper insights into the private credit market. 
Rob Fauber, president and CEO of Moody&#39;s, said, &quot;This is a real win-win, as Moody&#39;s customers gain access to MSCI&#39;s renowned ESG content and MSCI customers will gain access to Moody&#39;s world-class risk assessment expertise, data and insights.&quot; 
Henry A. Fernandez, chairman and CEO of MSCI, said, &quot;Sustainability remains one of the most important trends reshaping the global investment landscape, and the shift to private assets is another. This agreement will help MSCI expand our private company ESG coverage and deliver enhanced solutions across client segments and asset classes.&quot; 
This alliance doesn&#39;t affect Moody&#39;s Ratings, the credit rating agency, which will continue offering transparency on the material impacts of ESG factors on its credit ratings via its proprietary Credit Impact Scores and Issuer Profile Scores. Moody&#39;s Ratings will further keep providing its sustainable finance offerings, which include Second Party Opinions and Net Zero Assessments. Furthermore, MCO remains committed to providing its top-tier climate solutions to its customers.
This move aligns with Moody&#39;s aim to boost the scale of its business and augment its offerings and solutions. This is also demonstrated through the opportunistic buyouts undertaken by the company over the years. In 2023, it acquired SCRiesgo to deepen its presence in Central America and the Dominican Republic. In 2022, MCO bought 360kompany AG to strengthen its Know Your Customer capabilities, while in 2021, it acquired PassFort Limited.
Over the past six months, the company&#39;s shares have risen 10.4% compared with the industry&#39;s growth of 0.8%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/07/70084.jpg?v=1406197180" /> 
Image Source: Zacks Investment Research
Moody&#39;s currently carries a Zacks Rank #4 (Sell).
<h3>Other Financial Services Firms Taking Similar Steps</h3>
Last month, BlackRock Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blk#NYSE">BLK</a>) entered into a strategic partnership with GeoWealth, a financial technology firm, to expand its capabilities to cater to the needs of clients in the $37 trillion U.S. wealth market. This move aligns with the company&#39;s growth strategy to boost its offerings. 
BLK aims to offer custom models via GeoWealth&#39;s platform, enabling advisors to address client demand for private markets, direct indexing and fixed-income SMAs alongside traditional ETFs and mutual funds, all within a single account. 
Similarly, AssetMark Financial Holdings Inc.&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amk#NYSE">AMK</a>) wholly-owned subsidiary AssetMark Inc. entered into a strategic coalition with Morningstar Wealth. The transaction, approved by the board of directors of both companies, is expected to be closed in the second half of 2024, subject to regulatory approvals. 
AMK will acquire roughly $12 billion in assets from Morningstar Wealth Turnkey Asset Management Platform (&quot;TAMP&quot;) as part of the alliance. AssetMark&#39;s platform, which offers top-tier service, advisor technology, business consulting and a diligently selected group of investment strategists, will be accessible to financial advisors and clients on Morningstar Wealth&#39;s TAMP.
<a href="https://www.zacks.com/stock/news/2296306/moody-s-mco-forms-strategic-alliance-to-boost-esg-solutions?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2296306">To read this article on Zacks.com click here.</a>

Moody's Forms Strategic Alliance to Boost ESG Solutions

50 High Quality Dividend Stocks To Own For The Long Term

My Top 15 High Growth Dividend Stocks For September 2024

Tracking Dan Loeb's Third Point Portfolio - Q2 2024 Update

Nasdaq gets rare double-upgrade to Buy at BofA on data, software growth

Barclays analyst Manav Patnaik maintained a Buy rating on MSCI (MSCI – Research Report) today and set a price target of $700.00. The company's shar...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

MSCI

MSCI (MSCI) Forecast

MSCI (NYSE:MSCI) Stock, Quote.Headers.trade-ideas